Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8 (DD) - Mediclinic International Plc

25th Oct 2017 11:56

RNS Number : 5994U
J.P. Morgan Eq South Africa Prop
25 October 2017
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

J.P. Morgan Equities South Africa Proprietary Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Corporate Broker & Financial Advisor to Spire Healthcare Group plc

(e) Date dealing undertaken:

24 October 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

634,932

0.09

83,566

0.01

(2) Cash-settled derivatives:

 

655,552

0.09

1,250,459

0.17

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

TOTAL:

1,290,484

0.18

1,334,025

0.18

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(ZAR)

Ordinary Shares

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

Sale

426

3,032

2,442

158

531

467

1,773

452

469

625

426

 

138

2,540

461

3,918

6,156

2,519

2,789

516

548

1,197

11

1,639

3,071

249

272

2,456

45

1,211

4,303

297

70

370

187

426

561

75

770

1,507

6

1,773

924

3,055

1,613

24

483

350

547

726

100

588

13

173

31

374

374

22

374

187

374

601

3,070

384

471

187

187

112.1800

112.2100

110.0600

110.2200

111.5300

111.5400

112.2857

111.9500

112.0200

111.8100

112.9000

 

112.3100

112.7400

110.0600

111.1300

111.0400

111.0500

110.9700

110.2200

110.2100

110.0800

111.5400

111.5700

111.6900

111.9600

111.7300

112.0000

110.1500

110.0300

111.1100

110.8400

110.2600

111.7400

111.7100

111.7600

111.9000

110.1700

110.1600

111.6300

111.9100

112.2857

111.1400

111.2400

111.6700

112.7700

111.9500

111.9700

110.8500

110.9400

110.2500

110.0700

111.5900

111.6800

111.8100

111.8200

111.9300

111.9200

111.8300

111.6100

111.7700

110.2400

111.0300

110.9800

112.7800

111.9400

111.8600

 

 

 

 

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(ZAR)

Lowest price per unit paid/received

(ZAR)

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(ZAR)

Ordinary Shares

Equity Swaps

Long

 

Short

49,697

 

 1,773

 6,630

111.2191

 

112.2857

111.2690

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

 

Date of disclosure:

25 October 2017

Contact name:

Evangelos Galiatsatos

Telephone number:

020 7742 7272

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCOKPDPKBDDNKB

Related Shares:

MDC.L
FTSE 100 Latest
Value8,774.65
Change-17.15